Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary Interventions

NCT04497792 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Diabetes Mellitus
Percutaneous Coronary Intervention

Interventions

DRUG: Empagliflozin 10Mg Tab
DRUG: hypoglycemic therapy

Sponsor

Research Institute for Complex Problems of Cardiovascular Diseases, Russia